IBDEI1LD ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28251,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28251,1,4,0)
 ;;=4^706.8
 ;;^UTILITY(U,$J,358.3,28251,1,5,0)
 ;;=5^Xerosis
 ;;^UTILITY(U,$J,358.3,28251,2)
 ;;=^271931
 ;;^UTILITY(U,$J,358.3,28252,0)
 ;;=710.1^^162^1793^53
 ;;^UTILITY(U,$J,358.3,28252,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28252,1,4,0)
 ;;=4^710.1
 ;;^UTILITY(U,$J,358.3,28252,1,5,0)
 ;;=5^Scleroderma
 ;;^UTILITY(U,$J,358.3,28252,2)
 ;;=Scleroderma^108590
 ;;^UTILITY(U,$J,358.3,28253,0)
 ;;=250.80^^162^1793^65
 ;;^UTILITY(U,$J,358.3,28253,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28253,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,28253,1,5,0)
 ;;=5^Ulcer Of Calf, Diabetic
 ;;^UTILITY(U,$J,358.3,28253,2)
 ;;=Ulcer of Calf, Diabetic^267846^707.12
 ;;^UTILITY(U,$J,358.3,28254,0)
 ;;=695.10^^162^1793^31
 ;;^UTILITY(U,$J,358.3,28254,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28254,1,4,0)
 ;;=4^695.10
 ;;^UTILITY(U,$J,358.3,28254,1,5,0)
 ;;=5^Erythema Multiforme,Unsp
 ;;^UTILITY(U,$J,358.3,28254,2)
 ;;=^336759
 ;;^UTILITY(U,$J,358.3,28255,0)
 ;;=695.11^^162^1793^30
 ;;^UTILITY(U,$J,358.3,28255,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28255,1,4,0)
 ;;=4^695.11
 ;;^UTILITY(U,$J,358.3,28255,1,5,0)
 ;;=5^Erythema Multiforme, Minor
 ;;^UTILITY(U,$J,358.3,28255,2)
 ;;=^336634
 ;;^UTILITY(U,$J,358.3,28256,0)
 ;;=695.12^^162^1793^29
 ;;^UTILITY(U,$J,358.3,28256,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28256,1,4,0)
 ;;=4^695.12
 ;;^UTILITY(U,$J,358.3,28256,1,5,0)
 ;;=5^Erythema Multiforme, Major
 ;;^UTILITY(U,$J,358.3,28256,2)
 ;;=^336635
 ;;^UTILITY(U,$J,358.3,28257,0)
 ;;=695.19^^162^1793^32
 ;;^UTILITY(U,$J,358.3,28257,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28257,1,4,0)
 ;;=4^695.19
 ;;^UTILITY(U,$J,358.3,28257,1,5,0)
 ;;=5^Erythema, Other Multiforme
 ;;^UTILITY(U,$J,358.3,28257,2)
 ;;=^336639
 ;;^UTILITY(U,$J,358.3,28258,0)
 ;;=078.12^^162^1793^44
 ;;^UTILITY(U,$J,358.3,28258,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28258,1,4,0)
 ;;=4^078.12
 ;;^UTILITY(U,$J,358.3,28258,1,5,0)
 ;;=5^Plantar Wart
 ;;^UTILITY(U,$J,358.3,28258,2)
 ;;=^336720
 ;;^UTILITY(U,$J,358.3,28259,0)
 ;;=695.13^^162^1793^60
 ;;^UTILITY(U,$J,358.3,28259,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28259,1,4,0)
 ;;=4^695.13
 ;;^UTILITY(U,$J,358.3,28259,1,5,0)
 ;;=5^Steven-Johnson Syndrome
 ;;^UTILITY(U,$J,358.3,28259,2)
 ;;=^336636
 ;;^UTILITY(U,$J,358.3,28260,0)
 ;;=695.14^^162^1793^52
 ;;^UTILITY(U,$J,358.3,28260,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28260,1,4,0)
 ;;=4^695.14
 ;;^UTILITY(U,$J,358.3,28260,1,5,0)
 ;;=5^SJS-TEN Syndrome
 ;;^UTILITY(U,$J,358.3,28260,2)
 ;;=^336637
 ;;^UTILITY(U,$J,358.3,28261,0)
 ;;=695.15^^162^1793^63
 ;;^UTILITY(U,$J,358.3,28261,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28261,1,4,0)
 ;;=4^695.15
 ;;^UTILITY(U,$J,358.3,28261,1,5,0)
 ;;=5^Toxic Epidermal Necrolysis
 ;;^UTILITY(U,$J,358.3,28261,2)
 ;;=^336638
 ;;^UTILITY(U,$J,358.3,28262,0)
 ;;=V18.0^^162^1794^14
 ;;^UTILITY(U,$J,358.3,28262,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28262,1,4,0)
 ;;=4^V18.0
 ;;^UTILITY(U,$J,358.3,28262,1,5,0)
 ;;=5^Family H/O Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,28262,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,28263,0)
 ;;=V16.0^^162^1794^7
 ;;^UTILITY(U,$J,358.3,28263,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28263,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,28263,1,5,0)
 ;;=5^Family H/O Cancer Of GI Tract
 ;;^UTILITY(U,$J,358.3,28263,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,28264,0)
 ;;=V16.1^^162^1794^8
 ;;^UTILITY(U,$J,358.3,28264,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28264,1,4,0)
 ;;=4^V16.1
 ;;
 ;;$END ROU IBDEI1LD
